Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
£265 million investment in UCL spin-outs which could transform patient outcomes
Three UCL spin-out companies focused on delivering advanced therapeutics to treat a range of diseases received a substantial amount of investment following two initial public offerings worth £177 million ($235 million) combined and one Series B funding round of £88 million in June.
Novel method of analysis of stroke data
Latest news and highlights
Bringing innovation to life